Avidity Biosciences (NASDAQ:RNA) Price Target Cut to $48.00 by Analysts at Bank of America
Avidity Biosciences (NASDAQ:RNA – Free Report) had its target price decreased by Bank of America from $51.00 to $48.00 in a report published on Monday,Benzinga reports. Bank of America currently has a buy rating on the biotechnology company’s stock. Several other research firms have also weighed in on RNA. Scotiabank began coverage on Avidity Biosciences […]
Avidity Biosciences (NASDAQ:RNA – Free Report) had its target price decreased by Bank of America from $51.00 to $48.00 in a report published on Monday,Benzinga reports. Bank of America currently has a buy rating on the biotechnology company’s stock. Several other research firms have also weighed in on RNA. Scotiabank began coverage on Avidity Biosciences […]
